131 related articles for article (PubMed ID: 14592998)
1. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
Dewerchin M; Hérault JP; Wallays G; Petitou M; Schaeffer P; Millet L; Weitz JI; Moons L; Collen D; Carmeliet P; Herbert JM
Circ Res; 2003 Nov; 93(11):1120-6. PubMed ID: 14592998
[TBL] [Abstract][Full Text] [Related]
2. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
[TBL] [Abstract][Full Text] [Related]
3. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis.
Chowdhury V; Lane DA; Mille B; Auberger K; Gandenberger-Bachem S; Pabinger I; Olds RJ; Thein SL
Thromb Haemost; 1994 Aug; 72(2):198-202. PubMed ID: 7831651
[TBL] [Abstract][Full Text] [Related]
4. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
5. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
[TBL] [Abstract][Full Text] [Related]
6. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model.
Sorg H; Hoffmann JN; Menger MD; Lindenblatt N; Goehring P; Vollmar B
Thromb Haemost; 2006 Sep; 96(3):371-7. PubMed ID: 16953281
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
[TBL] [Abstract][Full Text] [Related]
9. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
[TBL] [Abstract][Full Text] [Related]
10. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
[No Abstract] [Full Text] [Related]
11. [Homozygous antithrombin type HBS deficiency; a family study].
Guermazi S; Elloumi-ZghaL H; Ben Hassine L; Romani S; Khalfallah N; Abdelhak S; Dellagi K
Pathol Biol (Paris); 2007 Jun; 55(5):256-61. PubMed ID: 17140748
[TBL] [Abstract][Full Text] [Related]
12. Recurrent leg ulcers and arterial thrombosis in a 33-year-old homozygous variant of antithrombin.
Shimizu K; Toriyama F; Ogawa F; Katayama I; Okajima K
Am J Hematol; 2001 Apr; 66(4):285-91. PubMed ID: 11279641
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of antithrombin strand 1C substitution mutations.
Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.
Zhou RF; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Wang XF; Wang HL; Wang ZY
Thromb Haemost; 2005 Dec; 94(6):1172-6. PubMed ID: 16411389
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin and heparin.
Carrell R; Skinner R; Warden M; Whisstock J
Mol Med Today; 1995 Aug; 1(5):226-31. PubMed ID: 17607884
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies to heparin polysaccharides bind to vascular endothelial cells].
Shibata S
Rinsho Byori; 1998 Dec; 46(12):1205-9. PubMed ID: 9916505
[TBL] [Abstract][Full Text] [Related]
17. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
[TBL] [Abstract][Full Text] [Related]
19. Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation.
Monien BH; Krishnasamy C; Olson ST; Desai UR
Biochemistry; 2005 Sep; 44(35):11660-8. PubMed ID: 16128566
[TBL] [Abstract][Full Text] [Related]
20. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
